Tumor3dsp. z o.o.
KRS: NIP: REGON:
Overview
Status
Deleted
Activity period
2015-05-14 – 2026-05-26
Registered address
ul. Długa 16, 85-034 Bydgoszcz, Poland
Electronic delivery address
AE:PL-83883-85291-DEWWC-37
Financials
The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Revenue
This companyUSD 997.36kMedianUSD 92.20kAverageUSD 1.47m
Net profit
This companyUSD -242.93kMedianUSD 2.47kAverageUSD 170.67k
Operating costs
This companyUSD 1.19mMedianUSD 85.28kAverageUSD 1.19m
Assets
This companyUSD 4.65mMedianUSD 40.84kAverageUSD 1.02m
Bank accounts
Registered as a VAT taxpayer on 2016-03-10. Active
42 1020 4027 0000 1102 2035 4590
17 1090 1359 0000 0001 3066 3136
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
4 public aid cases recorded, with a total value of $83,328.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 31, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $55,238$55,238 | Prezydent Miasta Poznań | |
| Jul 31, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $27,619$27,619 | Prezydent Miasta Poznań | |
| Jul 28, 2020 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $358$358 | Prezes Zakładu Ubezpieczeń Społecznych |
Tenders
No recorded participation in tenders.
Beneficial owners
| Person | Rights | |
|---|---|---|
Hubert Niedziela (36) | Większościowy wspólnik (75% udziałów) spółki pod firmą nuvra spółka z ograniczoną odpowiedzialnością (krs: 0001039767), która posiada 11,46% akcji w tumor3d spółka akcyjna oraz jest komplementariuszem spółki pod firmą nuvra spółka z ograniczoną odpowiedzialnością spółka komandytowo-akcyjna (krs: 0000480215), która posiada 28,20% akcji w tumor3d spółka akcyjna co razem daje beneficjentowi rzeczywisteumu pośrednie uprawnienia właścicielskie z 39,67% akcji w tumor3d spółka akcyjna |
Subsidiaries
Change history
| Date | Event | |
|---|---|---|
| 2026-05-26 | PKD change (Removed: 62.01.Z, 62.09.Z, 63.11.Z, 63.99.Z, 72.11.Z, 72.19.Z, 74.90.Z, 86.21.Z, 86.22.Z, 86.90.E) | |
| 2026-05-26 | Struck off the register | |
| 2025-09-24 | Address change (Al. Wielkopolska 29/8, 60-603, Poznań → Ul. Długa 16, 85-034, Bydgoszcz) | |
| 2025-09-24 | Share capital change (10,139,700.00 PLN → 11,630,400.00 PLN) | |
| 2022-12-22 | Share capital change (2,900,000.00 PLN → 10,139,700.00 PLN) |
FAQ
The company was registered in the Polish National Court Register (KRS) on May 14, 2015.
The headquarters is located at: ul. Długa 16, 85-034 Bydgoszcz.
The share capital of the company is PLN 11,630,400 (approx. $3.1 million).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
The company reported a revenue of $997,365 in 2024, which is an increase of 0.8% compared to 2023.
No, in 2024 the company was not profitable, reporting a net loss of $242,925. For comparison, in 2023 the loss was $603,319, meaning the company reduced its loss by 61.8%.
The largest operating cost category falls under external services. This category amounted to $729,711 in 2024, representing 61% of all operating expenses.
Last updated: 2026-08-02